Working with others
We work in partnership with experts in different fields who can help us achieve the greatest impact in the global fight against cancer.
By encouraging scientists to work together and share information, we can make sure breakthroughs in cancer research continue to be made – and that those discoveries benefit as many people affected by cancer as quickly as possible.
The National Awareness and Early Diagnosis Initiative (NAEDI) coordinates research and promotes programmes that ensure cancer is detected earlier.
Part of our Drug Development Office’s work is to invest in promising therapies that have been 'shelved' by pharmaceutical and biotechnology companies.
We gain access to these treatments through Clinical Development Partnerships (CDP), a joint initiative by Cancer Research UK and Cancer Research Technology.
Cancer Research Technology (CRT) is a technology development company owned by us. It helps identify promising research and transforms it into treatments, vaccines, and more effective ways to diagnose cancer.
All profits made by CRT are reinvested in Cancer Research UK to fund further research.
We help test new treatments before they’re made available to patients. These 'late phase' trials can involve thousands of patients and cost many millions of pounds. Where possible, we fund these trials alongside other charities, research councils, the pharmaceutical industry and the NHS.
The Experimental Cancer Medicine Centre Network (ECMC) is a £35 million initiative supported by Cancer Research UK and the Departments of Health for England, Scotland, Wales and Northern Ireland. They fund 19 Experimental Cancer Medicine Centres across the UK that bring scientists, doctors and patients together to develop new ways to treat and diagnose cancer.
We fund five research institutes:
- the Beatson Institute for Cancer Research in Glasgow
- the Cambridge Research Institute
- Oxford's Gray Institute for Radiation Biology & Oncology
- the London Research Institute
- the Paterson Institute for Cancer Research in Manchester.
The Francis Crick Institute (formerly the UKCMRI), based in London, will be a world-class centre for medical science, research and innovation. This ambitious project is funded by four of the UK’s leading biomedical research organisations: Cancer Research UK, the Medical Research Council, UCL (University College London) and the Wellcome Trust.
Cancer Research UK is a key member of the National Cancer Research Institute (NCRI). This 'virtual' institute was formed in 2001 to bring together the UK’s major funders of cancer research. By working together, members ensure that cancer research isn’t duplicated, and that their efforts are directed where they are needed the most.
The National Cancer Research Network (NCRN) was created in 2001 to coordinate and support clinical cancer research in the UK. Since it opened, the NCRN has more than doubled the number of cancer patients taking part in clinical trials, which will help new treatments reach patients more quickly.